StockData
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH) stock

AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3058% below fair value
$15.40−0.08 (-0.52%)

Close on Nov 17, 2026Market cap $2.06BP/E 6.7Yield –

Aurinia Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Aurinia Pharmaceuticals's market cap was $2.15B on Nov 11, 2026, against $2.13B a year earlier. Over the last 5 years it ranged from $613.92M to $2.96B, with a median of $1.29B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.15B+2.5%
2025Dec 31, 2025$2.10B+63.6%
2024Dec 31, 2024$1.29B-0.5%
2023Dec 29, 2023$1.29B+110.3%
2022Dec 30, 2022$613.92M-79.3%
2021Dec 31, 2021$2.96B+91.6%
2020Dec 31, 2020$1.55B-10.7%
2019Dec 31, 2019$1.73B+230.2%
2018Dec 31, 2018$524.58M+228.2%
2017Dec 29, 2017$159.84M–

More Aurinia Pharmaceuticals figures

See a number that looks wrong?